US EditionPublished • loading... • Updated
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel ...
Summary by Hastings Tribune
2 Articles
2 Articles
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled biomaterials for regenerative and...
·Manila, Philippines
Read Full Article
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel ...
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled biomaterials for regenerative and aesthetic applications, today announced that it has entered into an exclusive, worldwide license agreement with the…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
